← Journal/18 May 2026·7 min de lecture
What is broad-spectrum CBD? Definition and uses
Par The Phytogrammes team ·
Broad-spectrum CBD is a hemp extract from which the THC has been removed below the detection threshold (< 0.01 %), while the other cannabinoids (CBG, CBN, CBC) and the terpenes are retained. It sits midway between full spectrum (which carries traces of THC ≤ 0.30 %) and isolate (pure CBD at 99 %).

The market offers three families of CBD product with distinct chemical profiles. Broad spectrum is often described as "the best of both worlds": it keeps the rich profile of hemp without the risk attached to residual THC. Here is what the category actually means, and when it makes sense.
The technical definition
A broad-spectrum extract is produced in two stages. First comes an extraction (supercritical CO2 for preference, sometimes pharmaceutical ethanol) that captures the full set of cannabinoids and terpenes in the hemp. Then a step of liquid chromatography or selective filtration removes the delta-9-THC below the detection threshold, generally under 100 ppm (0.01 %).
The three formats on the French market
To see where broad spectrum sits, the benchmark is straightforward.
| Format | Contents | THC | Indication |
|---|---|---|---|
| Full spectrum | All cannabinoids + terpenes + flavonoids | ≤ 0.30 % | Wellbeing use with no testing constraint |
| Broad spectrum | All cannabinoids except THC + terpenes | < 0.01 % | Use where drug testing is a possibility |
| Isolate | Pure CBD at 99 %+ | None | Maximum safety, precise dosing |
Broad spectrum is aimed at users who want a rich chemical profile while limiting their exposure to THC.
Who is broad spectrum relevant for?
Several profiles lean towards broad spectrum rather than full spectrum:
- regular drivers anxious to reduce the risk of a positive saliva test. The Cour de cassation confirmed on 21 June 2023 that the commercial legality of a product does not exempt the driver;
- amateur or semi-professional athletes who wish to stay below the WADA thresholds for THC in competition. CBD itself has been permitted since 2018 under the WADA list;
- employees in sensitive posts subject to workplace saliva testing (transport, security roles);
- women planning a pregnancy or breastfeeding, for whom the precautionary principle applies to traces of THC;
- users who enjoy the aromatic profile of hemp (the terpenes) but would rather avoid THC.
Worth noting: broad spectrum greatly reduces the risk of a positive test without removing it altogether in chronic use. For maximum safety, isolate remains the format to favour.
The entourage effect and broad spectrum
The dominant commercial argument for broad spectrum is that it would allow the user to benefit from the entourage effect — the hypothesis that minor cannabinoids and terpenes amplify the action of CBD — without the constraint of THC.
That hypothesis remains under scientific investigation. Controlled clinical trials comparing isolate and broad spectrum at equal doses are rare and underpowered. No European authority has validated any health claim tied to the entourage effect. Brands therefore cannot assert that broad spectrum is "more effective" than isolate.
How to verify a broad spectrum
The certificate of analysis (CoA) from an accredited independent laboratory (Cofrac, ISO 17025) is the only reliable document. For a broad spectrum, it must show:
- The actual CBD content (to be compared with the label, discrepancy < 10 %).
- The delta-9-THC content: marked "ND" (not detected) or "< LOQ" (below the limit of quantification) — typically < 0.01 %.
- The cannabinoid profile: CBG, CBN and CBC present at meaningful concentrations (otherwise it is in reality an isolate).
- The absence of prohibited cannabinoids: HHC, H4CBD, H2CBD, HHCO, THCP, THCA, 10-OH-HHC, classified as narcotics by the ANSM in June 2024.
- The contaminants (heavy metals, pesticides, solvents) below the European Pharmacopoeia thresholds.
Without a CoA, or with an undated document, the words "broad spectrum" cannot be verified.
The legal framework in France
Broad spectrum may lawfully be sold in France, like any product derived from authorised hemp varieties whose finished THC content does not exceed 0.30 % (Conseil d'État, 29 December 2022). Note that since 15 May 2026 the DGAL has applied the European Novel Food regulation strictly. Oils sold as a "food supplement" without European authorisation are being withdrawn from the market. Cosmetic formats, and "wellbeing oil for external use", remain available.
The EFSA published on 9 February 2026 a provisionally safe daily dose of 0.0275 mg/kg/day of CBD, roughly 2 mg a day for a 70 kg adult. A useful benchmark for placing consumption against the dosages commonly sold (15 to 50 mg per dose of oil).
Key points
- Broad spectrum keeps minor cannabinoids and terpenes, with no quantifiable THC.
- An intermediate format between full spectrum (with THC ≤ 0.30 %) and isolate (pure CBD at 99 %).
- Suited to regular drivers, amateur athletes and employees in sensitive posts.
- The claimed entourage effect remains a hypothesis under investigation.
- Always insist on a certificate of analysis confirming the absence of THC and of prohibited cannabinoids.
- CBD is not a medicine. If you have any medical doubt, consult a healthcare professional.
Frequently asked questions
Broad spectrum or isolate for driving?
If you drive professionally or very regularly, isolate is safer because it contains no minor cannabinoids liable to interfere. For occasional use by a private driver, a broad spectrum certified free of THC already offers a very substantial reduction in risk.
Does broad spectrum cost more than full spectrum?
Often yes, because the additional chromatography step to remove the THC adds to production costs. The difference ranges from 10 to 30 % depending on the brand and the volumes.
Does a broad spectrum taste different from a full spectrum?
Slightly. Broad spectrum retains the terpenes and so keeps a vegetal aromatic profile, but the purification step can soften certain notes. An isolate, by contrast, is entirely neutral.
Is broad spectrum forbidden to pregnant women?
Like any CBD product, it is not advised for women who are pregnant, breastfeeding or of childbearing age. In June 2025 the ANSES proposed to the ECHA that CBD be classified as "presumed toxic to human reproduction" (category 1B). The precautionary principle applies.
How can I be sure a product really is broad spectrum?
The CoA must show minor cannabinoids (CBG, CBN, CBC) present at meaningful concentrations, and the absence of delta-9-THC. If the CoA lists only the dominant CBD without detailing the other cannabinoids, it is probably an isolate marketed as broad spectrum.
To explore our selection of broad-spectrum oils with a certificate of analysis confirming the absence of THC, [browse our spectres-chimie catalogue](/categorie-produit/extracts-cbd). CBD is not a medicine. If you have any medical doubt, consult a healthcare professional.
Sources
Written by the Phytogrammes team
Every article in this journal draws on primary sources (ANSM, EFSA, EUR-Lex, peer-reviewed publications) and on the lab's own practice: batch-by-batch HPLC analyses, measured cannabinoid profiles. Our approach.
Article published on . CBD is not a medicine.
Phytogrammes products that pair well
Further reading

sommeil·18 May 2026
CBD and occasional difficult nights: what science says in France
A sleepless night now and then affects half of French people. Here are the documented causes and the real place of CBD in an evening routine.

cbd-animal·18 May 2026
CBD for dogs in France: a considered buyer's guide
There is no veterinary marketing authorisation for CBD in France. Here is how to read a label, check a certificate of analysis and avoid products that put your dog at risk.

animaux·18 May 2026
CBD for dogs: what the French veterinary framework says
No veterinary marketing authorisation, THC toxic to dogs, unvalidated dosing: a review of CBD safety in dogs in France, with no therapeutic claim.



